What is the recommended daily dosage of vitamin C for adults, and what are the guidelines for therapeutic dosing in deficiency or specific conditions?

Vitamin C (Vitron C) Dosing Recommendations

For adults, the recommended daily intake of vitamin C is 75 mg/day for women and 90 mg/day for men according to current US guidelines, though European authorities recommend higher amounts (95-110 mg/day), and smokers require an additional 35-40 mg/day above baseline recommendations. 11

Standard Daily Dosing for Adults

The evidence reveals significant international variation in vitamin C recommendations, ranging from 40-220 mg/day depending on the underlying health philosophy 1:

• US RDA (2000): 75 mg/day for women, 90 mg/day for men 11
• European (EFSA/DACH, 2013): 95 mg/day for women, 110 mg/day for men 12
• UK/FAO/WHO: 40-45 mg/day (based solely on scurvy prevention) 11

The higher European recommendations are preferable as they aim to maintain adequate plasma vitamin C status rather than merely preventing scurvy, which represents a more clinically relevant endpoint for overall health 11.

Special Population Adjustments

Smokers

Smokers require 135 mg/day (women) or 155 mg/day (men) due to 40% higher metabolic turnover and lower plasma levels 2. This represents a critical clinical consideration often overlooked in practice.

Pregnancy and Lactation

• Pregnant women (4th month onward): 105 mg/day 2
• Lactating women: 125 mg/day 2

Children and Adolescents

• Ages 1-14 years: 20-85 mg/day (increasing with age) 2
• Ages 15-18 years: 90 mg/day (girls), 105 mg/day (boys) 2
• Infants <1 year: 20 mg/day 2

Therapeutic Dosing for Deficiency

For confirmed scurvy or severe deficiency, administer 1,000 mg (1 g) daily for 15 days 3. This therapeutic dose rapidly corrects deficiency and resolves clinical manifestations including hemorrhagic syndrome, weakness, and gingival bleeding.

Clinical Context for Deficiency Treatment

Scurvy develops after approximately 3 months without vitamin C intake 3. High-risk populations requiring screening include:

• Men living alone
• Elderly individuals
• Homeless populations
• Psychiatric patients
• Food faddists
• Those with poor fresh fruit/vegetable intake 3

Plasma ascorbic acid <2.5 mg/L confirms deficiency, though this must be interpreted considering acute phase response 3. Leukocyte ascorbic acid levels more accurately reflect total body stores but are not routinely available 3.

Over-the-Counter Formulations

The FDA-labeled dosing for standard vitamin C supplements is 500 mg (1 tablet) daily for adults and children ≥12 years 44. This exceeds the RDA but remains well below the tolerable upper limit.

Safety Considerations and Upper Limits

The Tolerable Upper Limit (UL) is 2,000 mg/day (2 g/day), based primarily on gastrointestinal upset at higher doses 56. However, specific monitoring is warranted for:

Critical Safety Warnings

• Glucose-6-phosphate dehydrogenase (G6PD) deficiency: Risk of hemolysis—avoid high doses 7
• Kidney stone history: Risk of oxalate nephropathy with high doses 7
• Renal insufficiency: Monitor for oxalate accumulation 7
• Glucometer interference: High-dose vitamin C can cause falsely elevated glucose readings 7
• Hypernatremia risk: Particularly with IV formulations 7

Optimal vs. Adequate Intake Debate

While 200 mg/day has been proposed as "optimal" for chronic disease prevention based on pharmacokinetic and observational data 8, this remains controversial. The evidence shows:

• Phase III randomized controlled trials have not consistently demonstrated chronic disease benefits from supplementation above RDA levels 8
• Observational studies and Phase II trials suggest benefits for hypertension, endothelial dysfunction, and inflammation at 200 mg/day 8
• The gap between preventing deficiency (40-90 mg/day) and potential optimization (200 mg/day) reflects fundamentally different health philosophies 11

Clinical Pitfall

Do not confuse oral supplementation with IV pharmacologic ascorbate—these represent entirely different interventions with distinct pharmacokinetics, safety profiles, and clinical applications 97. IV high-dose vitamin C (≥6 g/day) requires specialized monitoring and is not equivalent to oral supplementation.

Practical Recommendation Algorithm

1. Assess baseline risk: Identify smokers, elderly, poor diet, malabsorption
2. Standard healthy adults: 90 mg/day (men), 75 mg/day (women) minimum
3. Smokers: Add 35-40 mg/day to baseline (total 135-155 mg/day)
4. Pregnancy/lactation: 105-125 mg/day
5. Suspected deficiency: 1,000 mg/day × 15 days, then maintenance
6. Consider European targets (95-110 mg/day) for patients with cardiovascular risk factors or chronic inflammation 12
7. Screen for G6PD deficiency before high-dose therapy (>500 mg/day)

The evidence strongly supports moving beyond the minimalist "prevent scurvy" approach toward maintaining adequate plasma levels, particularly given the safety profile at doses up to 2,000 mg/day 156.